4-83467455-T-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_139076.3(ABRAXAS1):āc.680A>Cā(p.Lys227Thr) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000665 in 1,488,908 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_139076.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABRAXAS1 | NM_139076.3 | c.680A>C | p.Lys227Thr | missense_variant, splice_region_variant | 7/9 | ENST00000321945.12 | NP_620775.2 | |
ABRAXAS1 | NM_001345962.2 | c.353A>C | p.Lys118Thr | missense_variant, splice_region_variant | 6/8 | NP_001332891.1 | ||
ABRAXAS1 | XR_001741334.3 | n.708A>C | splice_region_variant, non_coding_transcript_exon_variant | 7/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABRAXAS1 | ENST00000321945.12 | c.680A>C | p.Lys227Thr | missense_variant, splice_region_variant | 7/9 | 1 | NM_139076.3 | ENSP00000369857.3 | ||
ABRAXAS1 | ENST00000611288.4 | c.335A>C | p.Lys112Thr | missense_variant, splice_region_variant | 3/5 | 5 | ENSP00000482434.1 |
Frequencies
GnomAD3 genomes AF: 0.000374 AC: 57AN: 152258Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000811 AC: 20AN: 246484Hom.: 0 AF XY: 0.0000751 AC XY: 10AN XY: 133218
GnomAD4 exome AF: 0.0000314 AC: 42AN: 1336650Hom.: 0 Cov.: 20 AF XY: 0.0000283 AC XY: 19AN XY: 670658
GnomAD4 genome AF: 0.000374 AC: 57AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.000457 AC XY: 34AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 12, 2018 | Variant summary: FAM175A c.680A>C (p.Lys227Thr) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00011 in 272568 control chromosomes, predominantly at a frequency of 0.0013 within the African subpopulation in the gnomAD database. The observed variant frequency within African control individuals in the gnomAD database is approximately 42 fold of the estimated maximal expected allele frequency for a pathogenic variant in FAM175A causing Hereditary Breast and Ovarian Cancer phenotype (3.1e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African origin. To our knowledge, no occurrence of c.680A>C in individuals affected with Hereditary Breast and Ovarian Cancer and no experimental evidence demonstrating its impact on protein function have been reported. A ClinVar submission from a clinical diagnostic laboratory (evaluation after 2014) cites the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely benign. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 12, 2024 | The p.K227T variant (also known as c.680A>C), located in coding exon 7 of the FAM175A gene, results from an A to C substitution at nucleotide position 680. The lysine at codon 227 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 31, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at